FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Turning Point Therapeutics Inc. (NASDAQ: TPTX) reported Q3 EPS of ($1.34), $0.07 worse than the analyst estimate of ($1.27). Revenue for the quarter came in at $460 thousand.
For earnings history and earnings-related data on Turning Point Therapeutics Inc. (TPTX) click here.
... More
